Quick Answer
CytoDyn Inc. reported Cash And Cash Equivalents At Carrying Value of $11.90 million for the year ending 2025.
- CytoDyn Inc. showed an increase of +282.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CytoDyn Inc.'s annual report (Form 10-K), filed with the SEC on July 25, 2025.
- XBRL data for this metric is available from 2003 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $285.0 thousand | Q3 2012: $66.2 thousand | Q4 2012: $1.43 million | Q1 2013: $412.0 thousand | Q3 2013: $676.5 thousand | Q4 2013: $10.13 million | Q1 2014: $7.40 million | Q3 2014: $2.30 million | Q4 2014: $2.38 million | Q1 2015: $1.67 million | Q3 2015: $2.83 million | Q4 2015: $3.25 million | Q1 2016: $10.20 million | Q3 2016: $4.44 million | Q4 2016: $8.81 million | Q1 2017: $7.80 million | Q2 2017: $1.78 million | Q3 2017: $946.2 thousand | Q4 2017: $1.30 million | Q1 2018: $4.95 million | Q3 2018: $4.75 million | Q4 2018: $772.4 thousand | Q1 2019: $1.59 million | Q3 2019: $1.80 million | Q4 2019: $409.5 thousand | Q1 2020: $7.06 million | Q3 2020: $18.20 million | Q4 2020: $29.41 million | Q1 2021: $14.29 million | Q3 2021: $6.53 million | Q4 2021: $8.88 million | Q1 2022: $1.36 million | Q3 2022: $4.68 million | Q4 2022: $2.40 million | Q1 2023: $5.11 million | Q3 2023: $2.03 million | Q4 2023: $147.0 thousand | Q1 2024: $1.40 million | Q3 2024: $24.92 million | Q4 2024: $21.34 million | Q1 2025: $16.40 million | Q2 2025: $11.90 million | Q3 2025: $9.33 million | Q4 2025: $4.98 million.
- Over the full 17 years of available data (2003 to 2025), CytoDyn Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 367,503.5%.
- Historical annual values: Fiscal year 2025: $11.90 million | Fiscal year 2024: $3.11 million | Fiscal year 2023: $2.54 million | Fiscal year 2022: $4.23 million | Fiscal year 2021: $33.94 million | Fiscal year 2020: $14.28 million | Fiscal year 2019: $2.61 million | Fiscal year 2018: $1.23 million | Fiscal year 2017: $1.78 million | Fiscal year 2016: $9.64 million | Fiscal year 2015: $1.05 million | Fiscal year 2014: $4.89 million | Fiscal year 2013: $603.7 thousand | Fiscal year 2012: $285.0 thousand | Fiscal year 2011: $1.04 million | Fiscal year 2010: $700.5 thousand | Fiscal year 2003: $3.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: